American National Red Cross / Biomedical Services Rel Links2

• American National Red Cross/Biomedical Services, Washington, D.C., July 13, 2004 Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., April 2, 2004, Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., March 8, 2004, Consent Decree Correspondence 
• American National Red Cross/Biomedical Services, Washington, D.C., February 11, 2004, Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., September 2, 2003, Consent Decree Correspondence 
• American National Red Cross/Biomedical Services, Washington, D.C., July 22, 2003, Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., April 15, 2003, Amended Consent Decree 
• American National Red Cross/Biomedical Services, Arlington, Virginia, April 14, 2003, Consent Decree Letter 
• American National Red Cross/Biomedical Services, Arlington, Virginia , 04/22/2002 to 12/20/2002 FDA Inspectional Observations 
• American National Red Cross/Biomedical Services, Washington, D.C., April 4, 2007 Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., November 15, 2006, Consent Decree Correspondence (regarding September 7, 2006, Adverse Determination Letter, paragraph X), (19 pages, 286 KB)  (PDF - 286KB) 
• American National Red Cross/Biomedical Services, Washington, D.C., November 21, 2006, NYPR Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., September 7, 2006, Adverse Determination Letter and Related Nov. 15th, 2006 Consent Decree Correspondence 
• American National Red Cross/Biomedical Services, Washington, D.C., July 27, 2006 Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., June 10, 2005 Modified Adverse Determination Letter 
• American National Red Cross/Biomedical Services, Washington, D.C., May 16, 2005 Adverse Determination Letter and Attachment 
• American National Red Cross/Biomedical Services, Washngton, D.C., March 28, 2005, Adverse Determination Letter